Guo Weixi, Liu Hongming, Zhong Ming, Qi Qinghua, Li Yibin
Department of Thoracic Surgery, The First Affiliated Hospital of Xiamen University.
Department of Medical Oncology, Xiamen Key Laboratory of Antitumor Drug Transformation Research, The First Affiliated Hospital of Xiamen University, Xiamen, China.
Anticancer Drugs. 2025 Apr 1;36(4):261-270. doi: 10.1097/CAD.0000000000001439. Epub 2023 Nov 16.
Micro-RNAs play essential roles in developing and progressing nonsmall cell lung cancer (NSCLC) and drug resistance. Nevertheless, the functions and mechanisms are partly explored. Therefore, the present study analyzes the effect of circ_0006528 and the mechanism of regulation of NSCLC cell progression by sponging miR-892a to regulate neuroblastoma rat sarcoma viral oncogene (NRAS) expression. Initially, circ_0006528 is identified using divergent primers-based PCR and RNase R exonuclease treatments. After administration of the designed circ_0006528-specific siRNA, the RT-qPCR analysis is used to determine the interference efficiency of siRNA. At the same time, cell growth, invasion, and migration are assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5 diphenyl tetrazolium bromide (MTT), Transwell, and scratch assays in the NSCLC cell lines [secretory pathway Ca2+-ATPase isoform 1 (SPCA-1) and A549] in vitro, respectively. Further, miR-892a inhibitor is added to the cells for functional recovery assay. Finally, the xenograft mouse model is constructed to explore the effect of circ_0006528 on tumor growth in vivo . The RT-qPCR analysis in 66 pairs of NSCLC cancer and noncancerous tissues revealed that circ_0006528 is highly expressed in NSCLC patient tissues. The RNase R experiments revealed that HSA_circ_0006528 is unaffected by RNase R exonuclease. MTT assay showed that knockdown of hsa_circ_0006528 by siRNA significantly decreased cell proliferation and viability in A549 and SPCA-1 cells. The luciferase reporter assay showed direct binding of hsa_circ_0006528 to miR-892a, and miR-892a targets binding NRAS. In addition, the miR-892a inhibitor terminated the hsa_circ_0006528 siRNA, triggering inhibition of proliferation, invasion, and migration of NSCLC cells. In summary, the study revealed that the knockout of hsa_circ_0006528 downregulation of NRAS expression by sponging miR-892a inhibited NSCLC cell growth and invasion.
微小RNA在非小细胞肺癌(NSCLC)的发生发展及耐药过程中发挥着重要作用。然而,其功能和机制尚未完全明确。因此,本研究分析了环状RNA_0006528(circ_0006528)通过海绵吸附微小RNA - 892a(miR - 892a)调控神经母细胞瘤鼠肉瘤病毒癌基因(NRAS)表达进而影响NSCLC细胞进展的作用及机制。首先,利用基于发散引物的聚合酶链反应(PCR)和核糖核酸酶R(RNase R)外切酶处理来鉴定circ_0006528。在给予设计好的circ_0006528特异性小干扰RNA(siRNA)后,采用逆转录定量聚合酶链反应(RT - qPCR)分析来确定siRNA的干扰效率。同时,分别通过3 - [4,5 - 二甲基噻唑 - 2 - 基] - 2,5 - 二苯基四氮唑溴盐(MTT)法、Transwell法和划痕实验,在体外对NSCLC细胞系[分泌途径Ca2 + - ATP酶同工型1(SPCA - 1)和A549]的细胞生长、侵袭和迁移能力进行评估。此外,向细胞中添加miR - 892a抑制剂进行功能恢复实验。最后,构建异种移植小鼠模型以探究circ_0006528对体内肿瘤生长的影响。对66对NSCLC癌组织和癌旁组织进行RT - qPCR分析发现,circ_0006528在NSCLC患者组织中高表达。RNase R实验表明,人源circ_0006528不受RNase R外切酶的影响。MTT实验显示,siRNA敲低hsa_circ_0006528可显著降低A549和SPCA - 1细胞的增殖和活力。荧光素酶报告基因实验表明,hsa_circ_0006528与miR - 892a直接结合,且miR - 892a靶向结合NRAS。此外,miR - 892a抑制剂可消除hsa_circ_0006528 siRNA的作用,从而抑制NSCLC细胞的增殖、侵袭和迁移。综上所述,本研究表明敲除hsa_circ_0006528通过海绵吸附miR - 892a下调NRAS表达,进而抑制NSCLC细胞的生长和侵袭。